Visit us at AOFAS

To discover how STIMULAN® can
make a difference in your cases
20-23 September 2023
Booth #413
Kentucky International Convention Center –
Louisville, KY

Visit us at EUROSPINE

To find out why STIMULAN®
is the perfect partner for spine surgery
4-6 October 2023
Booth #A36
Messe Frankfurt – Frankfurt, Germany

Visit us at EBJIS

To learn more about STIMULAN® and SynicemTM
12-14 October 2023
Booth #10
Congress Center Basel – Basel, Switzerland

Visit us at NASS

To discover how STIMULAN® can
make a difference in your cases
18-20 October 2023
Booth #1329
Los Angeles Convention Cente – Los Angeles, CA

Visit us at AAHKS

To find out why STIMULAN® is uniquely engineered
for the precision and control you demand every time
2-5 November 2023
Booth #1120
Gaylord Texan Resort & Convention Center
– Grapevine, TX

6 Jun 23
6 Jun 23
Biocomposites adds proprietary NanoBone® technology to its portfolio through the acquisition of Artoss GmbH
NanoBone® technology complements Biocomposites’ absorbable bone regeneration products

Artoss to benefit from Biocomposites established, global distribution network

Keele, UK, 6 June 2023 – Biocomposites, an international medical devices company that engineers, manufactures and…...
5 Jul 23
5 Jul 23
Biocomposites invests in Renovos Biologics – developers of the RENOVITE® nanoclay therapeutic delivery platform

RENOVITE ® nanoclay is a novel therapeutic delivery platform for precision regenerative medicine

Investment will help fund pre-market approval for use in spine, trauma and orthopaedics

Biocomposites, CEO, Michael Harris will join Renovos Biologics Board of Directors

Keele, UK, 5 July 2023 – Biocomposites, an international medical devices company that engineers, manufactures and…...
Introducing STIMULAN® to
Podiatrists and Tissue Viability Nurses

Diabetic foot osteomyelitis and diabetic foot ulcers
can be challenging to heal. Find out how STIMULAN can help.


The only calcium matrix approved for mixing with vancomycin, gentamicin and tobramycin for use in bone and soft tissue.

Explore our library

Our industry leading knowledge, dedication and experience is supported with over 400 peer
reviewed papers, presentations and posters.

Pioneering calcium compounds

Innovation is at the very heart of what we do, resulting in over 100 grants and registrations.

Your specialty

Access case studies, clinical and pre-clinical papers for musculoskeletal infection, trauma and spine to see how we are innovating across a wide range of clinical applications to help surgeons and their patients.

Musculoskeletal infections

Musculoskeletal infections, including infected non-unions, osteomyelitis and periprosthetic joint infections, are one of the biggest healthcare challenges of the 21st century.

As the rapid growth of antibiotic-resistant strains and biofilms continues to outpace the development of new antibiotics and antibiotic strategies, care delivery is becoming increasingly challenging and complicated.


The popularity of spine surgery differs around the world. The number of procedures performed in the USA is double the number performed in Western Europe, Canada and Australia combined, and five times the number in the UK.

In the USA, the number of spinal fusion procedures increased by 64% between 2002 and 2014, from approximately 268,000 to 414,000. The average cost per procedure has increased from $15,868 to $28,954 over the same period and was more than $12 billion in total in 2014.

Why Biocomposites?

At Biocomposites, we are pioneering calcium compound devices to regenerate and repair bone and soft tissue. With over 30 years’ experience of manipulating the surface chemistry and crystalline properties of calcium compounds, we engineer and manufacture products at the forefront of calcium technology.

  • Singular focus
  • Proprietary technology
  • Dedicated to quality
Learn more